ARMOUR Residential REIT, Inc. vs Revvity Inc — how do they compare? ARMOUR Residential REIT, Inc. trades at $16.72 (market cap $2.07B), while Revvity Inc trades at $116.5 (market cap $12.91B). The key difference: Revvity Inc is far larger — about 6.2× ARMOUR Residential REIT, Inc.'s market cap, and ARMOUR Residential REIT, Inc. pays the higher dividend (17.28%). Which is the better fit depends on your goals.
| ARR | RVTY | |
|---|---|---|
Market Cap | $2.07B | $12.91B |
Sector | Financials | Technology |
52-Week High | $19.12 | $117.75 |
52-Week Low | $14.05 | $82.26 |
Dividend Yield | 17.28% | 0.24% |
Enterprise Value | — | $15.23B |
Trailing returns across standard periods
ARMOUR Residential REIT Inc is a real estate investment trust that invests in residential mortgage-backed securities or RMBS. These are issued or guaranteed by U.S.-government-sponsored enterprises, such as Fannie Mae, Freddie Mac, or Ginnie Mae. The company's investment portfolio is composed of mortgage-backed securities, adjustable-rate mortgage securities, and multifamily mortgage-backed securities. In terms of total fair value, most Armour's investments are long-term, fixed-rate agency RMBS. Multifamily RMBS also represents a substantial amount. Fannie Mae guarantees most of the company's holdings. Armour derives substantially all its revenue as interest income from its investments.
Read more on ARR →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →